Bellerophon Therapeutics Operating Income

Bellerophon Therapeutics (BLPH) currently reports a operating income of $-11M as of September 2023. That compares with $-22M in the prior-year period — up 48.8% year over year. Use the charts on this page to explore Bellerophon Therapeutics's operating income history and peer comparisons.

Bellerophon Therapeutics's operating income increased from $-22M to $-11M — a 48.8% year-over-year increase (period ending September 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Bellerophon Therapeutics reported $-11M in operating income as of September 2023. That compares with $-22M in the prior-year period — up 48.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current operating income of $-11M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Bellerophon Therapeutics, and consider following BLPH for alerts when major investors trade the stock.

Bellerophon Therapeutics is classified in the Healthcare sector. On operating income, it currently shows $-11M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing BLPH with unrelated industries.